SRA880

• Description:

  SRA880 is a non-peptide and selective somatostatin sst (1) receptor antagonist. SRA880 exhibits antidepressant-like effects when in combination with Imipramine (HY-B1490A) [1].

• UNSPSC:

  12352005

• Target:

  Somatostatin Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/sra880.html

• Purity:

  98.22

• Solubility:

  DMSO : ≥ 100 mg/mL

• Smiles:

  OC(CC(O)=O)=O.CN1[C@@]2([H])[C@@](C[C@H](C1)C(N3CCN(C4=CC=C(C=C4)[N+]([O-])=O)CC3)=O)([H])CC5=C(OC)C=CC=C5C2

• Molecular Formula:

  C29H36N4O8

• Molecular Weight:

  568.62

• References & Citations:

  [1]Hoyer D, et al. SRA880, in vitro characterization of the first non-peptide somatostatin sst (1) receptor antagonist. Neurosci Lett. 2004 May 6;361 (1-3) :132-5.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, sealed storage, away from moisture)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [573984-99-3]